The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Thrombocythemia, Hemorrhagic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Thrombocythemia, Hemorrhagic


High impact information on Thrombocythemia, Hemorrhagic


Chemical compound and disease context of Thrombocythemia, Hemorrhagic


Biological context of Thrombocythemia, Hemorrhagic


Anatomical context of Thrombocythemia, Hemorrhagic


Gene context of Thrombocythemia, Hemorrhagic


Analytical, diagnostic and therapeutic context of Thrombocythemia, Hemorrhagic


  1. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F., Barbui, T. N. Engl. J. Med. (1995) [Pubmed]
  2. Effect of busulfan on oncornavirus-like activity in platelets and chromosomes in polycythemia vera and essential thrombocythemia. Brodsky, I., Fuscaldo, A.A., Erlick, B.J., Fuscaldo, K.E. J. Natl. Cancer Inst. (1977) [Pubmed]
  3. Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject. Gaetani, G.F., Ferraris, A.M., Galiano, S., Giuntini, P., Canepa, L., d'Urso, M. Blood (1982) [Pubmed]
  4. Thrombospondin in essential thrombocythemia. Lawler, J., Cohen, A.M., Chao, F.C., Moriarty, D.J. Blood (1986) [Pubmed]
  5. Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension. Gilbert, H.S., Praloran, V., Stanley, E.R. Blood (1989) [Pubmed]
  6. Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. Kaywin, P., McDonough, M., Insel, P.A., Shattil, S.J. N. Engl. J. Med. (1978) [Pubmed]
  7. An altered platelet granule glycoprotein in patients with essential thrombocythemia. Booth, W.J., Berndt, M.C., Castaldi, P.A. J. Clin. Invest. (1984) [Pubmed]
  8. High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia. Ferraris, A.M., Mangerini, R., Pujic, N., Racchi, O., Rapezzi, D., Gallamini, A., Casciaro, S., Gaetani, G.F. Blood (2005) [Pubmed]
  9. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Ding, J., Komatsu, H., Wakita, A., Kato-Uranishi, M., Ito, M., Satoh, A., Tsuboi, K., Nitta, M., Miyazaki, H., Iida, S., Ueda, R. Blood (2004) [Pubmed]
  10. Therapy of essential thrombocythemia with thiotepa and chlorambucil. Case, D.C. Blood (1984) [Pubmed]
  11. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia. Walther, E.U., Tiecks, F.P., Haberl, R.L. Neurology (1996) [Pubmed]
  12. Increased thromboxane biosynthesis in essential thrombocythemia. Rocca, B., Ciabattoni, G., Tartaglione, R., Cortelazzo, S., Barbui, T., Patrono, C., Landolfi, R. Thromb. Haemost. (1995) [Pubmed]
  13. Myelodysplastic transformation in a case of essential thrombocythemia treated with pipobroman. Messora, C., Bensi, L., Vanzanelli, P., Temperani, P., Carotenuto, M., Sacchi, S. Haematologica (1996) [Pubmed]
  14. Severe mesenteric ischemia due to primary thrombocythemia treated with prostacyclin. Nimmo, G.R., McInnes, G., Turner, A.R., Evan-Wong, A. Crit. Care Med. (1990) [Pubmed]
  15. The PRV-1 gene expression in essential thrombocythemia. Teofili, L., Martini, M., Guidi, F., Venditti, D., Leone, G., Larocca, M.L. Blood (2004) [Pubmed]
  16. Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia. Alvarado, Y., Cortes, J., Verstovsek, S., Thomas, D., Faderl, S., Estrov, Z., Kantarjian, H., Giles, F.J. Cancer Chemother. Pharmacol. (2003) [Pubmed]
  17. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia. LeBrun, D.P., Pinkerton, P.H., Sheridan, B.L., Chen-Lai, J., Dubé, I.D., Poldre, P.A. Cancer Genet. Cytogenet. (1991) [Pubmed]
  18. Essential thrombocythemia: scientific advances and current practice. Tefferi, A. Curr. Opin. Hematol. (2006) [Pubmed]
  19. The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia. Wadenvik, H., Kutti, J., Ridell, B., Revesz, P., Jacobsson, S., Magnusson, B., Westin, J., Vilén, L. Blood (1991) [Pubmed]
  20. A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification. Yoshida, H., Kondo, M., Ichihashi, T., Hashimoto, N., Inazawa, J., Ohno, R., Naoe, T. Cancer Genet. Cytogenet. (1998) [Pubmed]
  21. Platelets of patients affected with essential thrombocythemia are abnormal in plasma membrane and adenine nucleotide content. Leoncini, G., Maresca, M., Buzzi, E., Piana, A., Armani, U. Eur. J. Haematol. (1990) [Pubmed]
  22. The myeloproliferative disorders. An historical appraisal and personal experiences. Michiels, J.J. Leuk. Lymphoma (1996) [Pubmed]
  23. Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative disorders. Friedenberg, W.R., Roberts, R.C., David, D.E. Am. J. Hematol. (1992) [Pubmed]
  24. Dlk1 in normal and abnormal hematopoiesis. Sakajiri, S., O'kelly, J., Yin, D., Miller, C.W., Hofmann, W.K., Oshimi, K., Shih, L.Y., Kim, K.H., Sul, H.S., Jensen, C.H., Teisner, B., Kawamata, N., Koeffler, H.P. Leukemia (2005) [Pubmed]
  25. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia. Griesshammer, M., Bangerter, M., Schrezenmeier, H. Semin. Thromb. Hemost. (1997) [Pubmed]
  26. Acute promyelocytic leukemia developing in untreated essential thrombocythemia. Sato, N., Furukawa, T., Masuko, M., Hashimoto, S., Takahashi, H., Baba, M., Inano, K., Suzuki, N., Toba, K., Fuse, I., Aizawa, Y. Am. J. Hematol. (2002) [Pubmed]
  27. Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature. Senno, S.L., Pechet, L. J. Thromb. Thrombolysis (1999) [Pubmed]
  28. Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Wandl, U.B., Nagel-Hiemke, M., May, D., Kreuzfelder, E., Kloke, O., Kranzhoff, M., Seeber, S., Niederle, N. Clin. Immunol. Immunopathol. (1992) [Pubmed]
  29. Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea. van den Anker-Lugtenburg, P.J., Sizoo, W. Am. J. Hematol. (1990) [Pubmed]
WikiGenes - Universities